Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04FPW
|
||||
| Former ID |
DNC004751
|
||||
| Drug Name |
Des-AA1,4,5,13-[Tyr2,D-Trp8]-SRIF
|
||||
| Indication | Discovery agent | Investigative | [527385] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C74H88N12O14S2
|
||||
| Canonical SMILES |
CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(<br />CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C4<br />3)CC5=CC=CC=C5)CC6=CC=CC=C6)NC(=O)C(CC7=CC=C(C=C7)O)N)C<br />(=O)O)C(C)O)CC8=CC=CC=C8)C(C)O
|
||||
| InChI |
1S/C74H88N12O14S2/c1-42(2)76-38-50-26-24-49(25-27-50)36-58-69(94)85-63(43(3)87)72(97)82-59(35-47-20-12-7-13-21-47)70(95)86-64(44(4)88)73(98)84-62(74(99)100)41-102-101-40-61(83-65(90)54(75)32-48-28-30-52(89)31-29-48)71(96)80-57(34-46-18-10-6-11-19-46)66(91)78-56(33-45-16-8-5-9-17-45)67(92)81-60(68(93)79-58)37-51-39-77-55-23-15-14-22-53(51)55/h5-31,39,42-44,54,56-64,76-77,87-89H,32-38,40-41,75H2,1-4H3,(H,78,91)(H,79,93)(H,80,96)(H,81,92)(H,82,97)(H,83,90)(H,84,98)(H,85,94)(H,86,95)(H,99,100)/t43-,44-,54+,56+,57-,58+,59+,60+,61-,62+,63-,64-/m1/s1
|
||||
| InChIKey |
GYAXOXYXFASSKI-GAZSGENXSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Somatostatin receptor type 3 | Target Info | Inhibitor | [527385] | |
| Somatostatin receptor 1 | Target Info | Inhibitor | [527385] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.